U.S. flag

An official website of the United States government

NM_024867.4(SPEF2):c.579T>C (p.Ile193=) AND not specified

Germline classification:
Benign (1 submission)
Last evaluated:
Mar 29, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000455722.4

Allele description [Variation Report for NM_024867.4(SPEF2):c.579T>C (p.Ile193=)]

NM_024867.4(SPEF2):c.579T>C (p.Ile193=)

Gene:
SPEF2:sperm flagellar 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5p13.2
Genomic location:
Preferred name:
NM_024867.4(SPEF2):c.579T>C (p.Ile193=)
HGVS:
  • NC_000005.10:g.35644519T>C
  • NM_024867.4:c.579T>CMANE SELECT
  • NM_144722.4:c.579T>C
  • NP_079143.3:p.Ile193=
  • NP_653323.1:p.Ile193=
  • NC_000005.9:g.35644621T>C
  • NM_024867.3:c.579T>C
  • p.Ile193Ile
Links:
dbSNP: rs7706444
NCBI 1000 Genomes Browser:
rs7706444
Molecular consequence:
  • NM_024867.4:c.579T>C - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_144722.4:c.579T>C - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Clear Turn Off Turn On
  • Buruli Ulcer
    Buruli Ulcer
    A lesion in the skin and subcutaneous tissues due to infections by MYCOBACTERIUM ULCERANS. It was first reported in Uganda, Africa.<br/>Year introduced: 2008
    MeSH
  • Foot Ulcer
    Foot Ulcer
    Lesion on the surface of the skin of the foot, usually accompanied by inflammation. The lesion may become infected or necrotic and is frequently associated with diabetes or le...<br/>Year introduced: 1992
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000540419Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)		Benign
(Mar 29, 2016) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000540419.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024